YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSIS
The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Abstract
To investigate changes in protein expression by proteomic analysis in the sera of patients with sepsis and to identify new biomarkers of sepsis. A total of 45 consecutive patients with severe sepsis or septic shock (sepsis group), 22 healthy volunteers, and 23 patients undergoing off-pump coronary artery bypass grafting (control group). Serum samples from eight patients of each group underwent proteomic analysis involving removal of 12 major proteins and subsequent reversed-phase high-performance liquid chromatography fractionation and one-dimensional electrophoresis. The intensity of 41 bands (with 12 proteins identified) increased and that of 42 bands (with 22 proteins identified) decreased in the sepsis group. Results of proteomic analysis successfully validated by Western blotting and/or enzyme-linked immunosorbent assay for three proteins (YKL-40, lipocalin 2, and S100A9) increased in the sepsis group as well as two proteins (retinol-binding protein, vitamin D-binding protein) decreased. Serum YKL-40 levels (sYKL-40) on intensive care unit (ICU) admission were assessed by enzyme-linked immunosorbent assay between the two groups; resulting YKL-40 was significantly higher in the sepsis group (P < 0.001). Furthermore, sYKL-40 on ICU admission was significantly higher in patients with positive blood culture (P < 0.005), patients with septic shock (P < 0.05), and patients requiring continuous hemodiafiltration (P < 0.05) or hydrocortisone replacement therapy (P < 0.005) during subsequent treatment. A positive correlation between sYKL-40 and blood IL-6 level on ICU admission was noted in the sepsis group (r = 0.465, P < 0.01). YKL-40 identified by proteomic analysis is considered as a biomarker of sepsis. However, further investigation is needed to clarify its roles and clinical usefulness as a biomarker.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as is the iron siderophore-binding protein lipocalin-2”
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiology and Chronic Health Evaluation II (14) and Sequential Organ Failure Assessment scores (15) were also calculated on ICU admission.”
MethodBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J.-L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P. M., Sprung, C. L., Colardyn, F., & Blecher, S. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00016 · Cited by 3,463 · cited 1×
“The Acute Physiology and Chronic Health Evaluation II (14) and Sequential Organ Failure Assessment scores (15) were also calculated on ICU admission.”
MethodSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018 · cited 1×
“During the ICU stay, patients with severe sepsis or septic shock were treated according to international guidelines (16).”
Dellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium
Wasinger, V. C., Cordwell, S. J., Cerpa‐Poljak, A., Yan, J. X., Gooley, A. A., Wilkins, M. R., Duncan, M. W., Harris, R., Williams, K. L., & Humphery‐Smith, I. (1995) · ELECTROPHORESIS · doi:10.1002/elps.11501601185 · Cited by 962
Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung Function
Ober, C., Tan, Z., Sun, Y., Possick, J. D., Pan, L., Nicolae, R., Radford, S., Parry, R. R., Heinzmann, A., Deichmann, K. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708801 · Cited by 470 · cited 2×
“First, serum levels of YKL-40 in patients with severe sepsis or septic shock were extremely higher than those in patients with other diseases such as rheumatoid arthritis (22), asthma (23), liver fibrosis (24), Crohn disease (25), acute coronary syndrome (26), and cancer (27).”
BackgroundResult
Cited by
Chitinase-3 like-protein-1 function and its role in diseases
Zhao, T., Su, Z., Li, Y., Zhang, X., & You, Q. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00303-7 · Cited by 536
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“Note, however, that such methods need careful handling from a statistical point of view (e.g. Altman and Royston 2000; Broadhurst and Kell 2006; Hastie et al. 2001; Ioannidis 2005, 2008).”
BackgroundCommon variants of the vitamin D binding protein gene and adverse health outcomes
Malik, S., Fu, L., Juras, D. J., Karmali, M., Wong, B. Y. L., Gozdzik, A., & Cole, D. E. C. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.750262 · Cited by 151
Mass spectrometry for the discovery of biomarkers of sepsis
Ludwig, K. R., & Hummon, A. B. (2017) · Molecular BioSystems · doi:10.1039/c6mb00656f · Cited by 113
Chitinase-like Proteins are Candidate Biomarkers for Sepsis-induced Acute Kidney Injury
Maddens, B., Ghesquière, B., Vanholder, R. C., Demon, D., Vanmassenhove, J., Gevaert, K., & Meyer, E. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013094 · Cited by 98
“This is in agreement with increased plasma CHI3L1 concentrations in humans after endotoxin injection (37) and in patients with severe sepsis and septic shock (38).”
BackgroundInfluentialCan YKL-40 be a new inflammatory biomarker in cardiovascular disease?
Kastrup, J. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.04.007 · Cited by 94
Attenuation of Sepsis‐Induced Organ Injury in Mice by Vitamin C
Fisher, B. J., Kraskauskas, D., Martin, E. J., Farkas, D., Puri, P., Massey, H. D., Idowu, M. O., Brophy, D. F., Voelkel, N. F., Fowler, A. A., et al. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113497760 · Cited by 88
Gerin, F., Şener, Ü., Erman, H., Yılmaz, A., Aydin, B., Armutçu, F., & Gürel, A. (2015) · Inflammation · doi:10.1007/s10753-015-0296-9 · Cited by 90
YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?
Schultz, N. A., & Johansen, J. S. (2010) · Cancers · doi:10.3390/cancers2031453 · Cited by 91
“Plasma and cerebrospinal fluid concentration of YKL-40 is associated to severity and prognosis of patients with bacterial infection, and plasma YKL-40 may add independent information of prognosis [109–111,113].”
BackgroundHost Response Biomarkers in the Diagnosis of Sepsis: A General Overview
Parlato, M., & Cavaillon, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1776-1_15 · Cited by 67
Immune parameters and outcomes during Ebola virus disease
Reynard, S., Journeaux, A., Gloaguen, E., Schaeffer, J., Varet, H., Pietrosemoli, N., Mateo, M., Baillet, N., Laouenan, C., Raoul, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125106 · Cited by 57
“YKL 40, secreted by macrophages, was one of them and has been defined as a biomarker of sepsis and to be of importance in the physiopathology of this syndrome (41).”
BackgroundThe role of phytochemicals in sepsis: A mechanistic and therapeutic perspective
Alikiaii, B., Bagherniya, M., Askari, G., Johnston, T. P., & Sahebkar, A. (2020) · BioFactors · doi:10.1002/biof.1694 · Cited by 57
Richard‐Greenblatt, M., Boillat‐Blanco, N., Zhong, K., Mbarack, Z., Samaka, J., Mlaganile, T., Kazimoto, T., D’Acremont, V., & Kain, K. C. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz419 · Cited by 53
Sepsis biomarkers: an omics perspective
Liu, X., Ren, H., & Peng, D. (2014) · Frontiers of Medicine · doi:10.1007/s11684-014-0318-2 · Cited by 49
“Proteomics-based analyses revealed that YKL-40 has high expression in serum samples from septic patients; thus, YKL40 is considered a possible biomarker of sepsis [72].”
BackgroundPlasma YKL-40 and CHI3L1 in systemic inflammation and sepsis—Experience from two prospective cohorts
Kornblit, B. T., Hellemann, D., Munthe‐Fog, L., Bonde, J., Strøm, J. J., MADSEN, H. O., Johansen, J. S., & Garred, P. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.010 · Cited by 43
Kadowaki, M., Sangai, T., Nagashima, T., Sakakibara, M., Yoshitomi, H., Takano, S., Sogawa, K., Umemura, H., Fushimi, K., Nakatani, Y., et al. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0974-9 · Cited by 41
“Using this method, we successfully identified three proteins, including YKL-50, as promising biomarkers of sepsis ( Hattori et al. 2009 ).”
MethodSelf-citationPronounced Inflammatory Response to Endotoxaemia during Nighttime: A Randomised Cross-Over Trial
Alamili, M., Bendtzen, K., Lykkesfeldt, J., Rosenberg, J., & Gögenür, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087413 · Cited by 42
“YKL-40 is a lectin that is secreted by macrophages and neutrophils in patients with sepsis, bacterial pneumonia, meningitis, encephalitis, rheumatoid arthritis, inflammatory bowel diseases, and in patients with cancer [20,21].”
BackgroundVitamin D and critical illness outcomes
Christopher, K. B. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000328 · Cited by 40
Muñoz, B., Suárez‐Sánchez, R., Hernández‐Hernández, Ó., Franco‐Cendejas, R., Cortés, H., & Magaña, J. J. (2018) · Burns · doi:10.1016/j.burns.2018.04.016 · Cited by 38
Ghafouri, B., Carlsson, A., Holmberg, S., Thelin, A. G., & Tagesson, C. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1059-y · Cited by 35
“Vitamin D-binding protein (VDBP) is primarily known as a transport protein but was found to be downregulated in serum of experimental animals with systemic inflammation [34] and patients with sepsis [35, 36].”
BackgroundDelayed increase of S100A9 messenger RNA predicts hospital-acquired infection after septic shock*
Fontaine, M., Pachot, A., Larue, A., Mougin, B., Landelle, C., Venet, F., Allombert, C., Cazalis, M.-A., Monneret, G., & Lepape, A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182282a40 · Cited by 34
“Our data are in line with a recent proteomic study in which, of 41 serum proteins, S100A9 was found to be significantly increased in patients with severe sepsis (29).”
ResultThe inflammatory biomarker YKL ‐40 at admission is a strong predictor of overall mortality
Mygind, N. D., Iversen, K. K., Køber, L., Goetze, J. P., Nielsen, H., Boesgaard, S., Bay, M., Johansen, J. S., Nielsen, O. W., Kirk, V., et al. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12006 · Cited by 33
Glendenning, P., & Inderjeeth, C. A. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1074157 · Cited by 35
YKL-40: A New Biomarker in Cardiovascular Disease?
Mathiasen, A. B., Henningsen, K. M. A., Harutyunyan, M., Mygind, N. D., & Kastrup, J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.58 · Cited by 31
Sepsis Through the Eyes of Proteomics: The Progress in the Last Decade
Sharma, N. K., & Salomão, R. (2016) · Shock · doi:10.1097/shk.0000000000000698 · Cited by 27
“Unauthor results obtained by proteomic analysis for such patients have been fully validated by other well-established analytical technique (10, 11).”
MethodSogawa, K., Kodera, Y., Satoh, M., Kawashima, Y., Umemura, H., Maruyama, K., Takizawa, H., Yokosuka, O., & Nomura, F. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01336.x · Cited by 26
Self-citationHall, T. C., Bilku, D. K., Al-Leswas, D., Horst, C., & Dennison, A. R. (2011) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-011-0741-1 · Cited by 26
“Levels higher in sepsis compared to controls, but results biased and samples limited [31]”
ResultProteome analysis of hemofilter adsorbates to identify novel substances of sepsis: a pilot study
Hashida, T., Nakada, T., Satoh, M., Tomita, K., Kawaguchi, R., Nomura, F., & Oda, S. (2016) · Journal of Artificial Organs · doi:10.1007/s10047-016-0936-3 · Cited by 24
Self-citationThe diagnostic roles of neutrophil in bloodstream infections
Shao, S.-L., Cong, H., Wang, M., & Liu, P. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.10.007 · Cited by 23
Predictive value of serum gelsolin and Gc globulin in sepsis – a pilot study
Horváth‐Szalai, Z., Kustán, P., Szirmay, B., Lakatos, Á., Christensen, P. H., Huber, T., Bugyi, B., Mühl, D., Ludány, A., Miseta, A., et al. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0782 · Cited by 23
Abulaizi, M., Tomonaga, T., Satoh, M., Sogawa, K., Matsushita, K., Kodera, Y., Obul, J., Takano, S., Yoshitomi, H., Miyazaki, M., et al. (2011) · International Journal of Proteomics · doi:10.1155/2011/628787 · Cited by 22
“…a three-step proteome analysis involving removal of 12 abundant proteins and subsequent reversed-phase high-performance liquid chromatography fractionation and one-dimensional electrophoresis: we successfully identified three proteins including YKL-50 as a promising biomarker of sepsis [11].”
MethodInfluentialSelf-citationErdman, L. K., Petes, C., Lu, Z., Dhabangi, A., Musoke, C., Cserti-Gazdewich, C. M., Lee, C. G., Liles, W. C., Elias, J. A., & Kain, K. C. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-279 · Cited by 21
“CHI3L1 levels are increased in chronic inflammatory conditions and acute infections such as pneumonia, meningitis, and sepsis [24-26], and often correlate with disease severity and prognosis [20].”
BackgroundKimura, A., Sogawa, K., Satoh, M., Kodera, Y., Yokosuka, O., Tomonaga, T., & Nomura, F. (2012) · International Journal of Proteomics · doi:10.1155/2012/623190 · Cited by 21
“We recently developed a three-step serum proteome analysis involving removal of 12 abundant proteins and subsequent reversed-phase high-performance liquid chromatography fractionation and one-dimensional electrophoresis and identified three proteins including YKL50 as a promising biomarker of sepsis [36].”
MethodSelf-citationErtürk, A., Cüre, E., Cüre, M. C., Parlak, E., Kurt, A. N. C., & Oğullar, S. (2015) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.150891 · Cited by 19
“[8] Increased serum YKL-40 levels have also been reported in patients with sepsis,[24] and YKL-40 has been determined to be a good predictor of infl ammation in these patients.”
BackgroundYKL-40 in patients with end-stage renal disease receiving haemodialysis
Nielsen, T. L., Plesner, L. L., Warming, P. E., Pallisgaard, J. L., Dalsgaard, M., Schou, M., Høst, U., Rydahl, C., Brandi, L., Køber, L., et al. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1428359 · Cited by 19
Berghe, T. V., & Hoste, E. A. J. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0196-2 · Cited by 20
“On the other hand, targeted sequencing or mass spectrometric analysis of Ang2 Plasma Severe sepsis Organ dysfunction and injury [150, 151] Endocan Plasma Sepsis Severity of illness and mortality [152, 153] Cell-free DNA Plasma Critically ill Sepsis and mortality [154, 155] Critically ill No predictive value [156] Magn…”
BackgroundCombined Proteomic Analysis of Liver Tissue and Serum in Chronically Alcohol‐Fed Rats
Yamada, M., Satoh, M., Seimiya, M., Sogawa, K., Itoga, S., Tomonaga, T., & Nomura, F. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01883.x · Cited by 15
“Using this method, we identified YKL-50 as a promising biomarker of sepsis (Hattori et al., 2009) and vitronectin as an indicator of the early stages of breast cancer (Kadowaki et al.”
MethodSelf-citationSheng, Z., Yu, Z., Wang, M., Zhou, R., Chen, S., Yu, X., & Li, F. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101608 · Cited by 15
“CHI3L1, also known as YKL-40, has emerged as a recognized biomarker for sepsis, demonstrating a positive correlation with disease severity [14,41].”
BackgroundKjaergaard, A. D., Helby, J., Johansen, J. S., Nordestgaard, B. G., & Bojesen, S. E. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.010 · Cited by 15
Machine Learning Methods for Septic Shock Prediction
Darwiche, A., & Mukherjee, S. (2018) · International Conference on Artificial Intelligence and Virtual Reality (AIVR) · doi:10.1145/3293663.3293673 · Cited by 16
“Protein YKL-40 was investigated as a potential biomarker of septic shock [30].”
BackgroundLee, S., Lin, C., Wang, P.-H., Han, C., Yang, S., Chang, J. T., Lee, M., Lin, L., & Lee, M. (2012) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21500 · Cited by 13
Lautenbach, M. J., Wyss, K., Yman, V., Foroogh, F., Satarvandi, D., Mousavian, Z., Sondén, K., Wang, J., Álvez, M. B., Bergström, S., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.06.014 · Cited by 12
Clinical significance of serum YKL ‐40 in Behçet disease
Seo, J., Ahn, Y. J., Zheng, Z., Kim, B. O., Choi, M. J., Bang, D., & Kim, D. Y. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14376 · Cited by 11
Impact of negative emotions and insomnia on sepsis: A mediation Mendelian randomization study
Ni, F., Liu, X., & Wang, S. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108858 · Cited by 10
Hedetoft, M., Hansen, M. B., Madsen, M. B., Johansen, J. S., & Hyldegaard, O. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06760-x · Cited by 9
“Of notice, proteomic analysis has indicated YKL-40 as a promising biomarker in patients with severe sepsis and septic shock [22].”
BackgroundSipeki, N., Kovats, P. J., Deutschmann, C., Schierack, P., Roggenbuck, D., & Papp, M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i42.5728 · Cited by 9
Rahimi, M. H., Mollahosseini, M., Mirzababaei, A., Yekaninejad, M. S., Maghbooli, Z., & Mirzaei, K. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0422-1 · Cited by 9
Mashaly, G. E.-S., El-Kazzaz, S. S., & Zeid, M. S. (2020) · Open Journal of Immunology · doi:10.4236/oji.2020.101002 · Cited by 7
“YKL-40 has been indicated as a biomarker of sepsis [24].”
BackgroundBernard, I., Ransy, D. G., Brophy, J. C., Kakkar, F., Bitnun, A., Samson, L. M., Read, S., Soudeyns, H., Hawkes, M., & EPIC4 Study Group (2022) · Viruses · doi:10.3390/v14122602 · Cited by 7
Höhn, A., Iovino, I. Z., Cirillo, F., Drinhaus, H., Kleinbrahm, K., Boehm, L., ROBERTIS, E. D., & Hinkelbein, J. (2018) · BioMed Research International · doi:10.1155/2018/3576157 · Cited by 7
“Furthermore, other proteomic studies identified peptides as possibly useful sepsis biomarkers [4, 5].”
BackgroundBruhn, R., Skjøt‐Arkil, H., Skovsted, T. A., Brasen, C. L., Andersen, E. S., Heltborg, A., Hertz, M. I., Petersen, E. R. B., Mogensen, C. B., Torres, A., et al. (2025) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2025.110943 · Cited by 5
Elevated serum YKL-40 levels in patients with Kawasaki disease
Kim, K. H., Ahn, Y., Kim, D. Y., Kim, H.-S., & Kim, D. Y. (2016) · Biomarkers · doi:10.1080/1354750x.2016.1265000 · Cited by 5
Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates—A Pilot Study
Steletou, E., Metallinou, D., Margeli, A. P., Giannouchos, T. V., Michos, A. G., Kanaka‐Gantenbein, C., Papassotiriou, I., & Siahanidou, T. (2023) · Children · doi:10.3390/children10050772 · Cited by 5
“As far as other biomarkers were concerned, they presented a positive correlation between YKL-40 and IL-6 levels in the acute phase of sepsis [35].”
BackgroundResultInfluentialAn Overview of Proteomics on Sepsis
Camprubí–Rimblas, M. (2015) · Journal of Physical Chemistry & Biophysics · doi:10.4172/2161-0398.1000183 · Cited by 4
“Nevertheless, YKL-40 must be assessed in other clinical trials despite this first promising result, as it is necessary to validate its diagnostic value [40-42].”
BackgroundEvaluation of CRRT effects on pyemic secondary AKI by serum cartilage glycoprotein 39 and Annexin A1
Wu, Y., Wang, L., Meng, L., Cao, G., & Zhang, Y. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3691 · Cited by 4
“Cartilage glycoprotein 39 (YKL-40) and Annexin A1 are two newly identified inflammatory factors, with possible links to the incidence and development of pyemia and AKI (9).”
BackgroundResearch Advances in Biomarker for Sepsis
Peng, D., & Liu, X. (2016) · Springer eBooks · doi:10.1007/978-981-10-2425-2_15 · Cited by 4
“In clinic, YKL-40 was identified with proteomics analysis on a significantly higher expression level in serum samples from sepsis patients and considered as a possible biomarker of sepsis [81].”
BackgroundImproving Septic Shock Prediction with AdaBoost and Cox Regression Model
Darwiche, A., El-Geneidy, A., & Mukherjee, S. (2021) · International Conference on Consumer Electronics and Computer Engineering (ICCECE) · doi:10.1109/iccece51280.2021.9342457 · Cited by 4
“Studies were performed on Protein YKL-40 to check if it could indicate septic shock [30].”
MethodChi-Lectins: Forms, Functions and Clinical Applications
Gupta, R. K., & Gupta, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1065-2_19 · Cited by 4
Proteomics-Based Disease Biomarkers
Misek, D. E., Kondo, T., & Duncan, M. W. (2011) · International Journal of Proteomics · doi:10.1155/2011/894618 · Cited by 4
Hirasawa, H. (2011) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.3893/jjaam.22.85 · Cited by 3
Self-citationBabel, J., Košuta, I., Brajković, A. V., Vrančić, A. L., Premužić, V., Rogić, D., & Duraković, N. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195991 · Cited by 2
“However, they were significantly lower than those previously found in severe bacterial infections, such as severe sepsis, septic shock [27], and streptococcal bacteremia [22], where values were as high as 1000 ng/mL, a threshold we did not observe throughout our study at any point.”
BackgroundErdman, L. K. (2012) · TSpace (University of Toronto) · Cited by 3
Yu, J., Kim, T. H., Park, S.-S., Han, S., Yun, J., Son, D. J., Choi, J.-K., Jeon, I., & Hong, J. T. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01564-y · Cited by 1
“It acts as a cytokine and growth factor and is involved in various inflammatory and neurodegenerative diseases (Berres et al. 2009; Hattori et al. 2009; Rathcke and Vestergaard 2009; Seol et al. 2009; Furuhashi et al. 2010; Zheng et al. 2010; Bara et al. 2012).”
Utility of Biomarkers in Sepsis: Mirror Reflection of Inner Truculent Devil
Kota, S. K., Meher, L. K., Rao, E. S., Jammula, S., Kota, S. K., & Modi, K. D. (2013) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v12i1.13349 · Cited by 1
Zhang, L., He, H., Wang, J., & Sheng, D. (2015) · PubMed · Cited by 1
YKL-40 as Biomarker: Focus on Cardiovascular Disease
Mygind, N. D., & Kastrup, J. (2015) · Biomarkers in disease · doi:10.1007/978-94-007-7696-8_11 · Cited by 1
WHAT'S NEW IN SHOCK, OCTOBER 2009?
Weil, B. R., & Meldrum, D. R. (2009) · Shock · doi:10.1097/shk.0b013e3181b43785
Kodera, Y. (2016) · SEIBUTSU BUTSURI KAGAKU · doi:10.2198/electroph.60.1
Self-citationDevelopment of pretreatment technics for serum protein and peptides using electrophoresis
Kodera, Y., & Kawashima, Y. (2015) · SEIBUTSU BUTSURI KAGAKU · doi:10.2198/electroph.59.112
Self-citationVitamin D and Critically Ill Intensive Care Unit Patients
Christopher, K. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00117-6 · Cited by 1
Determination of serum YKL-40 levels in patients with brucellosis
Sezgin, F. M., & Nar, R. (2019) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.472868
“They also stated that it could be a biomarker of sepsis based on the proteomic analysis they had conducted but further studies were needed to clarify its clinical benefits [18].”
BackgroundMorić, R. L. (2011)
YKL-40 as Biomarker: Focus on Cardiovascular Disease
Mygind, N. D., & Kastrup, J. (2014) · Springer eBooks · doi:10.1007/978-94-007-7740-8_11-1
Role of YKL-40 in cutaneous and systemic diseases
Elsayed, H. T. I., Neinaa, Y. M. E., Alshenawy, H. A., & Gamei, M. M. (2023) · International Journal of Dermatology Venereology and Leprosy Sciences · doi:10.33545/26649411.2023.v6.i1b.144
“According to various studies (32-34) Serum levels of YKL-40 in those suffering from bacteremia, streptococcus pneumoniae, and sepsis are 10 times higher than those in normal people ([32-34]).”
BackgroundWang, S., Dong, N., Tingting, X., Li, Y., & Xing, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3286487/v1
Amrein, K., & Christopher, K. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00056-2
Gambella, A., Senetta, R., Falco, E. C., Ricci, A. A., Mangherini, L., Tampieri, C., Fissore, J., Orlando, G., Manetta, T., Mengozzi, G., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1372195
Evaluating the Influence of CHI3L1 and PI3 Methylation in Allergic and Nonallergic Asthma
Baos, S., Cremades‐Jimeno, L., de Pedro, M. Á., López-Ramos, M., Fernández‐Santamaría, R., Rosales-Ariza, C., Quiralte, J., Florido, F., González‐Mangado, N., Rodríguez‐Nieto, M. J., et al. (2025) · Biomolecules · doi:10.3390/biom15101363
Hedetoft, M., Hansen, M. B., Madsen, M. B., Johansen, J. S., & Hyldegaard, O. (2021) · Figshare · doi:10.6084/m9.figshare.16779886
Hedetoft, M., Hansen, M. B., Madsen, M. B., Johansen, J. S., & Hyldegaard, O. (2021) · Figshare · doi:10.6084/m9.figshare.16779889
Epigenetic alterations in sepsis
Carrasqueiro, G. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
A nomogram based on serum CHI3L1 for predicting IVIG nonresponse in children with Kawasaki disease
Zou, J., Duan, Y., Luo, D., Liu, D., Liu, B., Zhao, J., & Li, G. (2026) · European Journal of Pediatrics · doi:10.1007/s00431-025-06690-9
“Interestingly, the expression of CHI3L can be induced during infection [51], such as sepsis in adults and neonates [52, 53].”
Lactylated chitinase-3-like protein 1 promotes the development of sepsis
Wei, S., Wang, X., Yan, H., Wang, X., & Yang, B. (2026) · Central European Journal of Immunology · doi:10.5114/ceji/204065
“Elevated levels of CHI3L1 have been shown to be associated with poor outcomes in septic patients, indicating its potential as a prognostic biomarker [11, 12].”
Turrel-Davin, F. (2011) · theses.fr (ABES) · doi:10.70675/9de36ffcz654bz4cc6z8ca9z6c25ac664abe
Metadata
- Authors
- Hattori, N., Oda, S., Sadahiro, T., Nakamura, M., Abe, R., Shinozaki, K., Nomura, F., Tomonaga, T., Matsushita, K., Kodera, Y., Sogawa, K., Satoh, M., & Hirasawa, H.
- Affiliations
- Chiba University (JP)
- Kitasato University (JP)
- Chiba University Hospital (JP)
- Corresponding author
- Hattori, Noriyuki
- Oda, Shigeto
- Sadahiro, Tomohito
- Nakamura, Masataka
- Abe, Ryuzo
- Shinozaki, Koichiro
- Hirasawa, Hiroyuki
- ORCID
- Venue
- Shock
- Published
- 2009-10
- Volume
- 32
- Issue
- 4
- Pages
- 393-400
- ISSN
- 1073-2322 (ISSN-L)
- OpenAlex
- W2077667419
- Cited by
- 83
- References
- 42
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 1 · 2016: 8 · 2015: 8 · 2014: 5 · 2013: 4 · 2012: 7
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Shock (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- YKL-40, sepsis, septic shock, serum biomarkers, serum proteome, neutrophil gelatinase-associated lipocalin, S100A9, interleukin-6, hydrocortisone replacement, hemodiafiltration, blood culture, intensive care unit admission
- MeSH terms
- Lipocalin-2, Chitinase-3-Like Protein 1, Acute-Phase Proteins, Aged, Chromatography, High Pressure Liquid, Enzyme-Linked Immunosorbent Assay, Female, Glycoproteins, Humans, Male, Middle Aged, Proto-Oncogene Proteins, Retinol-Binding Proteins, Shock, Septic, Vitamin D-Binding Protein, Blotting, Western, Interleukin-6, Sepsis, Lectins, Calgranulin B, Adipokines, Lipocalins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.